Table 4.
Hazard ratios from the adjusted multistate Markov model.
| Adjustment set 1 |
Adjustment set 2 |
|||
|---|---|---|---|---|
| State 1 to State 2 | State 2 to State 1 | State 1 to State 2 | State 2 to State 1 | |
| FIB-4 (≥1.3 vs. <1.3) | 1.42 (1.02, 2.00) | 0.93 (0.61, 1.43) | 1.44 (1.03, 2.01) | 0.94 (0.62, 1.43) |
| NFS (≥−1.455 vs. <−1.455) | 1.07 (0.72, 1.57) | 0.56 (0.34, 0.91) | 1.02 (0.69, 1.50) | 0.47 (0.29, 0.78) |
| Echo | ||||
| None/mild fatty liver | Reference | Reference | Reference | Reference |
| Moderate fatty liver | 1.12 (0.78, 1.60) | 1.16 (0.77, 1.77) | 1.12 (0.79, 1.60) | 0.95 (0.63, 1.43) |
| Severe fatty liver | 1.80 (1.00, 3.22) | 1.61 (0.83, 3.12) | 1.72 (0.98, 3.00) | 1.15 (0.61, 2.15) |
Data are shown as hazards ratio (95% confidence interval).
The bold text indicates statistical significance.
Adjustment set 1: Age, sex, hypertension, metabolic syndrome, obesity, uric acid, and glycated hemoglobin.
Adjustment set 2: Age, sex, dyslipidemia, metabolic syndrome, obesity, insulin resistance, and glycated hemoglobin.
FIB-4: fibrosis-4 score; NFS: non-alcoholic fatty liver disease fibrosis score.